Avalon GloboCare (ALBT) Gains from Sales and Divestitures (2017 - 2025)
Avalon GloboCare's Gains from Sales and Divestitures history spans 9 years, with the latest figure at $80000.0 for Q4 2025.
- For Q4 2025, Gains from Sales and Divestitures fell 1.78% year-over-year to $80000.0; the TTM value through Dec 2025 reached $80000.0, down 1.78%, while the annual FY2025 figure was $80000.0, 1.78% down from the prior year.
- Gains from Sales and Divestitures reached $80000.0 in Q4 2025 per ALBT's latest filing, roughly flat from $80000.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $651668.0 in Q3 2021 to a low of $19137.0 in Q1 2023.
- Average Gains from Sales and Divestitures over 5 years is $231701.7, with a median of $107803.0 recorded in 2023.
- Peak YoY movement for Gains from Sales and Divestitures: tumbled 95.73% in 2021, then grew 0.97% in 2022.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $85750.0 in 2021, then increased by 0.97% to $86583.0 in 2022, then grew by 24.51% to $107803.0 in 2023, then fell by 24.45% to $81450.0 in 2024, then decreased by 1.78% to $80000.0 in 2025.
- Per Business Quant, the three most recent readings for ALBT's Gains from Sales and Divestitures are $80000.0 (Q4 2025), $80000.0 (Q3 2025), and $80000.0 (Q2 2025).